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aims: To construct and validate a short scale for the assessment of the severity of visual 
height intolerance (vHI) and acrophobia.
Methods: The questionnaire was developed from two earlier representative epidemio-
logical studies (n = 5,529). Items were applied in a telephone survey of a representative 
population-based sample.
results: A total of 1,960 persons were included. The life-time prevalence of vHI was 
32.7% (f: 36.1%; m: 28.4%); 12% of these persons fulfilled the psychiatric criteria of 
acrophobia. Rasch analysis of 11 items on severity, symptoms, and triggers resulted in 
an 8-item scale with good fit to the model. The score differentiated well between persons 
with and without acrophobia. The distribution of the scores on the metric scale of the 
questionnaires of those individuals with acrophobia is separate and distinct from that of 
susceptibles without acrophobia, although there is some overlap.
conclusion: Our proposed short questionnaire (vHISS, see Table 1 and Supplementary 
Material) allows a continuous quantification of the severity of vHI within a metric interval 
scale from 0 to 13. The diagnosis of acrophobia can be established by including two 
additional questions.
Keywords: fear of heights, visual height intolerance, acrophobia, questionnaire, metric interval scale, rasch analysis
inTrODUcTiOn
Epidemiological studies usually focus on a definition of fear of heights as a subtype of specific phobias. 
The criteria of fear of heights are based on the diagnostic features of anxiety and panic attacks elicited 
by exposure to heights (1). The frequency of fear of heights is reported to have a life-time prevalence 
of 3.1–6.4% (2–4). A cross-sectional epidemiological study on 3,517 individuals representative of 
the general population revealed that the life-time prevalence of visual height intolerance (vHI) of 
varying degrees of severity, including fear of heights, amounts to 28% (women 32%, men 25%) (5). 
A subsequent study (n =  2,012) on clinical characteristics almost exactly replicated the life-time 
prevalence of vHI (28.5%; women 32.4%, men 24.5%) (4). There is an inter- and intraindividual con-
tinuum stretching from fear of heights (acrophobia) to a less-pronounced vHI, to which the category 
of a specific phobia does not apply. Physiological visual height imbalance (prevalence 100%) should 
be distinguished from vHI (prevalence 28%; clinical relevance in about 50%) and acrophobia (preva-
lence about 5%), a specific phobia (1). The latter diagnosis is defined in the ICD-10 (6) and DSM-V 
TaBle 1 | a metric interval scale for estimating the severity of visual 
height intolerance (vhi).
Visual height intolerance severity scale (vhiss)
Question
Have you already experienced 
vHI while looking from a 
height? (distressing instability 
when standing or moving)
Yes □ No □
Continue to fill out the rest of 
the questionnaire only if you 
answered “yes.”
Continue Finished
1. Because of your vHI, 
how much difficulty did you 
recently have doing sports?
0 □ No difficulty
1 □ Any difficulty (a little/moderately/quite 
a lot/very much)
2. Because of your vHI, 
how much difficulty did you 
recently have in your daily 
activities?
0 □ No difficulty
1 □ A little
2 □ Moderately/quite a lot/very much
3. Because of your vHI, how 
much is your quality of life 
affected?
0 □ Not at all
1 □ A little
2 □ Moderately/quite a lot/very much
4. I have vHI when exposed 
to heights
0 □ … occasionally
1 □ … often/frequently/always
5. Now I have vHI that is … 0 □ … less strong than before
1 □ … just as strong as before
2 □ … stronger than before
6. I have/had vHI for longer 
than 6 months
0 □ No
1 □ Yes
list a
7. What bodily symptoms do 
you feel when exposed to 
heights? (multiple answers 
possible)
□ a. Trembling
□ b. Palpitations
□ c. Inner agitation
□ d. Sweating/moist hands
□ e. Light-headedness
□ f. Postural (to-and-fro) dizziness
□ g. Weakness in the knees
□ h. Instability of stance and gait
□ i. Malaise/queasy feeling in the 
stomach
□ j. Oppression
□ k. Fearfulness
□ l. Mental image of falling
□ m. Gait disorder
□ n. Others ………
□ None of the above
(Continued)
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(7) by the following criteria: an intense fear; avoidance of exposure 
to heights; one of the vegetative symptoms like trembling, palpi-
tation, sweating, inner agitation; and two other symptoms from 
the diagnostic symptom list. A time criterion of at least 6-month 
duration is required. The non-medical Anglo-American com-
munity uses the same term to refer to a more or less-pronounced 
vHI that does not generally fulfill the above criteria.
Questionnaires used up to now to validate susceptibility to 
fear of heights either compare self-reports and overt-behavioral 
procedures (8) or measure height-relevant interpretation biases 
to help assess the relationship between biased interpretations 
and symptoms of acrophobia (9). A reliable questionnaire is 
not available for evaluating susceptibility to and severity of vHI, 
including acrophobia. It was our aim to construct and validate an 
easy-to-handle short questionnaire that can be used for a reliable 
evaluation of susceptible individuals.
When developing a scale, the specific objectivity of its candi-
date items should be taken into account. One of the most relevant 
properties of an outcome measure is its specific objectivity. This 
property assumes that an easy item is more likely to be completed 
than a difficult item, and that a person with high ability is more 
likely to complete an item than a person with low ability. Specific 
objectivity also means that the single sum score is able to measure 
the underlying trait of the person and that this score is valid 
irrespective of the abilities of the observed population and the 
difficulty of the items. This ensures that all the items included in 
the scale measure the same trait. Also, by testing specific objec-
tivity, redundant items can be identified, i.e., items that do not 
contribute to knowledge about the person’s abilities and can be 
easily dropped, thus leading to a more concise scale. The benefit 
of such a quantitative questionnaire of susceptibility to heights is 
that it allows at least five applications:
• provides inclusion criteria and characteristics for susceptible 
individuals for scientific investigations and clinical trials;
• estimates the severity and the medical necessity of a recom-
mended therapy;
• assesses quantitatively the spontaneous course or the effective-
ness of therapy in follow-up studies;
• weighs the implications for potential professional restrictions;
• detects psychiatric comorbidity in susceptibles.
The Objective of this study was to validate a questionnaire 
that yields a quantitative measure of the severity of vHI. In the 
following, we present a short and robust questionnaire (Table 1; 
Supplementary Material: the downloadable English and German 
versions of Table 1) that is both easy to perform and to interpret. 
This questionnaire provides a metric interval scale rather than a 
mere grouping by different grades of severity.
MaTerials anD MeThODs
Development of the Questionnaire by 
“Distilling” the relevant Questions
The questionnaire was constructed from two more extensive 
questionnaires used in earlier representative epidemiological 
studies: one (n = 3,517) on the prevalence and determinants of 
vHI (5) and the other (n = 2,012) on clinical characteristics and 
psychiatric comorbidity patterns (4). Items were selected based 
on researchers’ clinical experience and based on a qualitative 
study in susceptible individuals (10).
We conducted a cross-sectional telephone survey of individu-
als representative of the general German population (n = 1,960). 
We considered this the best strategy for an optimal sample, 
Visual height intolerance severity scale (vhiss)
list B
8. vHI is induced by 
my … (multiple answers 
possible)
□
□
□
□
□
□
□
□
Standing on or climbing up a tower
Standing on or walking over a bridge
Standing on or walking up steps
Standing on or climbing up a ladder
Standing on or walking on a balcony
Looking out of a window
Standing or walking on a scaffolding
Standing or walking on a roof
□ Riding on a carousel or a Ferris wheel
□ Riding in a ski lift or gondola
□ Hiking/mountain climbing
□ Rock climbing
□ Other situations. If yes, please name
□ …………………………………
□ …………………………………
additional questions for the diagnosis of acrophobia
9. Do you feel very intense 
fear or extremely strong fear 
when exposed to heights?
□ Yes
□ No
10. I try in advance to avoid 
exposure to heights
□ No
□ Yes
Scoring instructions for the vHISS.
The scale is based on a set of eight questions for determining the severity of vHI. 
Two of the questions are lists: one of symptoms and one of triggers. Two additional 
questions are for the assessment of acrophobia.
1. Severity of vHI.
• Sum up the score of items 1–6.
• Add up the number of symptoms reported from List A (item 7). If there are less 
than 4 symptoms, add 0 to the total score; if there are 4 or more symptoms, add 
1 to the total score.
• Likewise, add up the number of triggers from List B (item 8). If there are less than 
4 triggers, add 0 to the total score. If there are 4–6 triggers, add 1 to the total 
score. For 7–9 triggers, add 2 to the total score. For 10 or more triggers, add 3 
to the total score.
The sum of items 1–6, plus items of List A plus items of List B yields the total severity 
score.
Severity score: 
□ □ □ □ □ □ □ □ □ □ □ □ □
1 2 3 4 5 6 7 8 9 10 11 12 13
2. Diagnosis of acrophobia.
To meet DSM-V criteria for the diagnosis, one must have
• At least one of the vegetative symptoms (a.–d.) from List A.
• Two other additional symptoms from List A.
• A positive response to item 6 (duration of at least 6 months) of the severity scale 
(yes).
• A positive response to items 9 and 10 (yes).
Acrophobia: 
	 
yes    no
TaBle 1 | continued
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although face-to-face interviews may provide more detailed 
individual information.
The questionnaire initially consisted of 16 questions (for 
original source, see Supplementary Material; note: a German 
translation was used since the survey was performed in 
Germany), the first of which was to determine the lifetime 
presence or absence of vHI or fear of heights: “Have you already 
experienced vHI (distressing instability when standing or 
moving) while looking from a height?” Only those who responded 
with “yes” continued. Eight questions were related to the severity 
of the condition (not strong, somewhat strong, moderately strong, 
quite strong, very strong), to how this susceptibility restricts the 
individual in daily activities and sports, and to the general impair-
ment of quality of life. In addition to the specific triggers, bodily 
symptoms, frequency of occurrence, and the duration of the 
susceptibility (longer than 6 months?), behavioral consequences 
of the susceptibility were determined. Additionally, participants 
were asked if they had already undergone therapy or planned to 
do so. Based on practical conside rations, all quantitative questions 
were scored on a 5-point scale: not at all, a little, moderately, quite 
a lot, and very much. We also asked participants to evaluate their 
overall susceptibility to heights (not strong, somewhat strong, 
moderately strong, quite strong, and very strong).
The survey was conducted according to the official directive 
on representative telephone-based market research involving 
the general population (infratest telephone master sample) 
and had a three-stage sampling design. It allowed us to select a 
limited sample of individuals aged 14 and older. This ensured an 
unbiased sample selection that excluded clustering effects. The 
multi-stratified, geographically based probability sampling of 
households allowed an additional random selection of defined 
targets. The study was performed by trained interviewers.
To create a scale to determine the severity of vHI, we chose 11 
items (see Table 2) for testing. The objectivity of these 11 items 
was tested in a random subsample of 200 susceptible participants.
To establish the psychiatric diagnosis of acrophobia, the follow-
ing items had to be fulfilled [adapted from Ref. (4)]: intense fear; one 
from the items trembling, palpitation, inner agitation, sweating; 
two from the items light-headedness, to-and-fro vertigo, weakness 
in the knees, instability of stance and gait, queasy-stomach feeling, 
fearfulness, others; eliciting situations with visual height stimuli 
had to be actively avoided or endured with intense fear; a time 
criterion of at least 6 months of duration; any avoidance, anxious 
anticipitation, or distress in the feared situation had to interfere 
negatively with a person’s daily routine or social activities.
statistical analyses
Descriptive Analysis
Percentages were used for categorical variables, while mean 
values and SDs were applied for numeric variables.
Rasch Analysis for Testing Objectivity
The Rasch model is a mathematical model that makes assump-
tions about response patterns resulting from rating scales. If data 
from a scale fits the expectations of a Rasch model, the criteria of 
specific objectivity are considered fulfilled. To fulfill the assump-
tions of a Rasch model, monotonicity, unidimensionality, and 
local independence of a scale have to be tested.
The Partial Credit Model (PCM)
It was used because it accounts for items with varying thresholds 
(11). The adequacy of the PCM was tested by a Likelihood ratio 
test.
Monotonicity
To investigate whether the various response levels of the scale 
work as anticipated, the empirical distribution of the thresholds 
TaBle 2 | items included in the partial credit model and their rescaling.
score
item 0 1 2 3
Because of your visual height intolerance (vHI), how much difficulty did you recently have in sports  
(engaging in competitive and formal or informal organized games, alone or in a group)?
S1 Not at all Moderately
Because of your vHI, how much difficulty did you recently have in your daily activities? S2 Not at all Moderately Quite a lot
Because of your vHI, how much is your quality of life affected? S3 Not at all Moderately Quite a lot
I have already experienced once vHI when exposed to heights S4 Occasionally Often/always
Now I have vHI that is … S5 Less strong 
than before
Just as strong as 
before
Stronger than 
before
I have/had vHI for longer than 6 months S6 No Yes
Number of symptoms (List A) S7 (<4) (≥4)
Number of different triggers (List B) S8 (<4) (4–6) (7–9) (10+)
Do you feel a very strong fear or extremely strong fear when exposed to vHI? S9
I try in advance to avoid exposure to heights S10
I quit as fast as possible all situations of acute exposure to heights S11
Items S9–S11 did not show good fit to the model and were therefore eliminated.
Sums yield a raw score from 0 to 13 where 0 = least severely affected and 13 = most severely affected.
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was examined by looking at category probability curves. If thresh-
olds are disordered, the difficulty of the response level does not 
correspond to the respective ability of the tested person. In the 
case of disordered thresholds, response levels were collapsed to 
resolve the problem.
Unidimensionality
Dimensionality was examined by residual principal components 
analysis (12). Items with positive factor loadings were considered 
candidates for a valid scale. The remaining items with negative 
factor loadings were examined by their ability to form a separate 
scale.
Local Independence
Local independence was tested by person-item residual correla-
tion analysis. Items are locally independent, if the response to a 
specific item is not affected by the response to another item, once 
the latent underlying trait is accounted for (13). For example, the 
items “How much are you restricted in your activities of daily life” 
and “How much are you restricted in your sporting activities” are 
correlated. However, they are independent of each other, once the 
underlying trait, i.e., vHI, is accounted for (14).
Differential Item Functioning (DIF)
Each item of the scale has to be consistent and work indepen-
dently of person factors, e.g., of sex or age of the respondent. 
Accordingly the DIF is tested across subgroups of person factors. 
For the analysis of DIF, the person factors age group, sex, and class 
intervals were treated as factors of an ANOVA. Their ANOVA 
statistics should be non-significant. If an item showed DIF, we 
removed it from the scale (15).
Fit of the Data to the Rasch Model
To assess overall fit, we investigated the item-trait interaction 
score. Good fit is indicated by a non-significant chi-square 
probability value (13). Additionally, two item-person interaction 
statistics (for item and for person fit) were used as indicators for 
overall fit. For both, a mean of zero and an SD of 1 indicate perfect 
fit to the model. On an individual level, the fit was investigated 
for person and item. The individual-person fit indicates how a 
person fits the Rasch model, i.e., individual-person fit residuals 
should be between −2.5 and +2.5. The individual-item-fit indi-
cates how well an item fits the Rasch model. A non-significant 
individual-item-fit (based on a chi-squared test) indicates suf-
ficient fit. Fit residuals such as the total of items deviating from 
the model were also assessed. They should lie within the range 
of ±2.5.
Internal Consistency
The person separation index (PSI) indicates how well the scale 
differentiates between patients. The PSI is close to 0, if all the 
persons are in a similar location; it approaches 1, the more the 
persons are spread across the item continuum (16). A PSI of >0.7 
is generally found to be acceptable (17).
Targeting of the Scale
Targeting of items and persons was assessed using the Person-
Item Threshold Distribution map, in which person locations 
are plotted together with item threshold locations. The signifi-
cance level was set at 0.05. The Bonferroni method was applied 
as adjustment for multiple testing; it yielded a significance 
level of 0.05/k, where k is the number of tests carried out 
simultaneously.
Convergent Construct Validity
To assess convergent construct validity of the analyzed scale, the 
Spearman correlation coefficient of the sum score of the scale 
was calculated using the general question about how severely an 
individual was affected as external reference (Self-rated severity: 
“How severe is your vHI?”).
For this study, the questionnaire was used and analyzed in 
its German version (see Supplementary Material). We provide a 
preliminary English translation. So far, the English version has 
not been validated cross-culturally.
Descriptive analyses were carried out with SAS V9.2. RUMM 
2030 was used for the Rasch analysis (Perth, RUMM Laboratory).
TaBle 3 | summary measures of model fit from the start to the final set.
items Persons item-trait-interaction
location Fit residual location Fit residual
N (no. of items) Mean sD Mean sD Mean sD Mean sD chi-squared p-Value Person separation index*
Start 200 (11) 0.00 0.96 0.17 3.22 −0.15 0.80 −0.23 0.75 258.41 (99) 0.000 0.64
Mid-point 200 (10) 0.00 1.12 0.03 1.15 −0.16 1.15 −0.20 0.82 113.35 (90) 0.047 0.67
Final 200 (8) 0.00 0.90 0.11 1.09 −0.50 1.10 −0.16 0.82 72.25 (64) 0.224 0.61
Summary statistics of a selected mid-point is provided to demonstrate the iterative approach.
*Person separation indices can only be interpreted if there is sufficient overall fit of the data to the Rasch model, i.e., the p-value is non-significant.
FigUre 1 | Person-item threshold distribution map of the scale. This indicates how persons and their abilities relate to item difficulty. The smaller the item 
difficulty, the higher the probability that an item will be completed. The information curve indicates the proportion of information provided by the items.
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resUlTs
A total of 640 (females: 388) of the 1,960 (females: 1,073) partici-
pants indicated that they had experienced vHI; this corresponds 
to a prevalence of 32.7% (females: 36.1%; males: 28.4%). The 
overall evaluation comprised the data for all 640 susceptibles. 
The general state of health of the participants corresponded 
to that of the general population (see question 11). In the self-
evaluation of the overall susceptibility, a relevant severity of vHI 
was estimated by 72% (n  =  458) as being moderately strong 
(38%), quite strong (23%), or very strong (10%). The remaining 
28% (n  =  182) rated the severity as only somewhat strong or 
not strong. Sporting activities were felt restricted (moderately 
to very much) in 17%, everyday life activities in 14%; the quality 
of life was reduced in 12% (moderately to very much) and in 
an additional 22% by a little. The most frequent triggers were 
tower, scaffolding, roof, and ladder in about 70% of susceptibles, 
whereas everyday situations like standing on a balcony, a stair-
case, or looking out of a window elicited vHI in only 25–40% of 
susceptibles.
In most of the susceptibles vHI occurred occasionally (63%), 
in the others frequently or always. In about 60%, the severity of 
vHI varied over time becoming stronger than before in 38%. The 
most frequent bodily symptoms were malaise/queasy feeling in 
the stomach region (79%) and fearfulness (75%; 44% scaled their 
fearfulness as very or extremely strong), followed by instability of 
stance and gait (67%), inner agitation (61%), oppression (60%), 
and a mental image of falling (56%). The questions as to how 
susceptible individuals cope with vHI revealed that 70–80% try 
to avoid or quit as fast as possible situations that elicit distressing 
vHI or fear of heights. On the other hand, 24% reported that at 
least occasionally they expose themselves intentionally to heights. 
Acrophobia as defined in ICD-10 (6) and DSM-V (7) was fulfilled 
in 12.0% of susceptibles (n = 77; females: 49).
rasch analysis
The objectivity of the items was investigated in a random 
subsample of 200 participants. Five of the initial items of the 
questionnaire showed disordered thresholds and were therefore 
rescored. Residual principal component analysis indicated 
6Huppert et al. Severity of Visual Height Intolerance
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FigUre 2 | score distributions of the visual height intolerance severity scale stratified by presence (yes, n = 77) or absence (no, n = 562) of 
acrophobia. Histograms are shown with overlaid normal and kernel densities. Diamonds in box plots indicate mean scores, whiskers display the maximum and 
minimum observations below and above the 1.5 interquartile range (upper fence), circles are maximum values above the upper fence.
unidimensionality. Three items showed local dependency with 
residual correlations above 0.3 (S9–S11); two items also showed 
DIF by age group (S10, S11). One item showed individual-item 
misfit (S9). Therefore, all three items were removed. The remain-
ing eight items showed a good fit to the model. Iterative results 
are shown in Table 3.
Person fit residuals indicated good individual fit. Internal 
consistency as quantified by the PSI was 0.61. Figure 1 shows 
the Person-Item Threshold Distribution map. This plot shows 
that the items are well distributed over the range of person 
abilities.
The final scale yielded a raw score ranging from 0 to 13, 
where 0 = least severely affected and 13 = most severely affected. 
Convergent construct validity was calculated with the full 
sample of n = 640. The correlation of the raw score to self-rated 
severity was moderate (r  =  0.46). Individuals with acrophobia 
scored significantly higher than those without acrophobia (mean 
score = 10 vs. mean score = 5, p < 0.0001) (see Figure 2).
DiscUssiOn
The questionnaire (Table  1) revealed a lifetime prevalence 
of vHI of 32.7% with a gender preponderance of females 
(females: 36.1%; males: 28.4%). This is slightly higher than the 
lifetime prevalence determined in two earlier cross-sectional 
epidemiological studies, where it amounted to 28% (4, 5). The 
data include both the psychiatrically defined specific phobia fear 
of heights/acrophobia and the less severe forms of height intoler-
ance. The frequency of acrophobia amounted to 12% of the 640 
susceptible individuals, i.e., 3.9% of the total of 1,960 surveyed 
individuals. This corresponds to the frequency reported in earlier 
surveys of the general population which ranged from 3.1 to 6.4% 
(2–4). The validity of our questionnaire is further supported by 
the results that simply measure the self-reported general suscep-
tibility to vHI and acrophobia (Figure 2). However, the metric 
interval scale of 0–13 points in our questionnaire calculated on 
the basis of eight questions better discriminates the severity of 
vHI in the individual, especially between less or more severely 
affected (Figure 2). As evident in Figure 3, a comprehensive self- 
report measure only correlates moderately with the raw score. 
Apparently, individuals cannot reliably discriminate between “very 
strong” and “quite strong” or between “not strong” and “some what 
strong.”
This is in line with the literature showing that adjectival scales 
are prone to bias because the meaning of terms such as “very,” 
“quite,” or “often” is influenced by individual interpretation and 
not always consistent (18).
One major advantage of the resulting interval scale is that a 
psychometrically sound sum score can be calculated that lends 
itself to parametric statistics.
7Huppert et al. Severity of Visual Height Intolerance
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FigUre 3 | association of self-reported severity of visual height intolerance (vhi) and the newly developed vhi severity score. Diamonds indicate mean 
scores, whiskers display the maximum and minimum observations below and above the 1.5 interquartile range (upper fence), circles are maximum values above the 
upper fence. The figure shows how subjects cannot reliably differentiate between “very strong” and “quite strong” or between “not strong” and “somewhat strong.”
To establish the diagnosis of acrophobia, questions 9 and 10 
have to be added to the basic eight-question questionnaire. These 
questions are concerned with the symptoms of intense fear and 
an overt-behavioral avoidance when exposed to certain height 
stimuli. The distribution of the scores on the metric scale of the 
questionnaires of those individuals with acrophobia is separate and 
distinct from that of susceptibles without acrophobia (Figure 2), 
although there is some overlap. The latter demonstrates that the 
diagnostic criteria of acrophobia are not only fulfilled by those 
individuals with the highest scores. For this reason, we hesitate to 
categorize the metric scale from 0 to 13 into groups such as mild, 
medium, and severe.
The questionnaire has not been tested for its robustness in 
short-term repeated use or for its longitudinal validity, which is 
particularly important in follow-up and treatment studies. In an 
earlier study, the course of illness and the degree of social impair-
ment were evaluated for a sample of 574 individuals with vHI, 128 
of whom fulfilled the DSM-5 diagnostic criteria of acrophobia 
(19). More than two-thirds exhibited a persistent or worse course, 
particularly those with acrophobia. Female sex and psychiatric 
comorbidity also predicted an unfavorable course. This means 
that untreated vHI in adults is mostly a chronic, more or less 
distressing disability. This does not hold for prepubertal primary 
school children aged 8–10 years who also showed a prevalence 
of vHI of about one-third (20). However, in contrast to the 
adult-onset type of the condition, vHI in children appears to take 
a benign spontaneous course.
Our current experience with the above-described short ques-
tionnaire compared to the more comprehensive ones used in our 
previous epidemiological studies affirms its suitability as a tool for 
the potential applications listed in the Introduction.
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